Global patent index - EP 1064003 A1

EP 1064003 A1 2001-01-03 - NEUROTROPHIC PROPERTIES OF IPGS AND IPG ANALOGUES

Title (en)

NEUROTROPHIC PROPERTIES OF IPGS AND IPG ANALOGUES

Title (de)

NEUROTROPISCHE EIGENSCHAFTEN DER INOSITOLPHOSPHOGLYCANE UND DEREN ANALOGE

Title (fr)

PROPRIETES NEUROTROPHIQUES DES IPG AND ANALOGUES D'IPG

Publication

EP 1064003 A1 (EN)

Application

EP 98962574 A

Priority

  • GB 9803847 W
  • GB 9801899 A

Abstract (en)

[origin: WO9938516A1] Inositolphosphoglycans (IPGs) or inositol-containing IPG analogues can be used to specifically cause neuron proliferation or neuron differentiation, and in particular neurite outgrowth. P-type IPGs or chiro-inositol containing analogues cause neurite outgrowth and A-type IPGs or myo-inositol containing analogues cause neuron proliferation. Compositions comprising these agents and their medical uses are also disclosed.

IPC 1-7 (main, further and additional classification)

A61K 31/70

IPC 8 full level (invention and additional information)

C07H 15/207 (2006.01); A61K 31/70 (2006.01); A61K 31/7028 (2006.01); A61K 31/7034 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01)

CPC (invention and additional information)

A61K 31/7034 (2013.01); A61K 31/7048 (2013.01)

Citation (search report)

See references of WO 9938516A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9938516 A1 19990805; AU 1770899 A 19990816; CA 2318584 A1 19990805; EP 1064003 A1 20010103; GB 9801899 D0 19980325; JP 2002501899 A 20020122

INPADOC legal status

2002-03-06 [18W] WITHDRAWN

- Ref Legal Event Code: 18W

- Date of withdrawal: 20020104

2001-01-03 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000821

2001-01-03 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE